One wrong assumption about timing, coverage or cost can leave retirees paying more than expected. Before signing up, it’s ...
Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...
The Daily Overview on MSN
Medicare will cover obesity drugs under Trump deal, from $50
President Trump has successfully negotiated a groundbreaking deal to include obesity drugs under Medicare coverage, marking a ...
1don MSN
Medicare Just Announced Its 2026 Premiums, and It's Bad News for Social Security's Dual Enrollees
In mid-June, the Medicare Trustees Report had estimated the Part B premium would rise by a scorching-hot 11.5% to $206.20 per ...
The 9.7% increase in the cost of Medicare Part B premiums for 2026 is due to several factors, including projected growth in ...
Senior citizens are the latest group of Americans to face steep increases in their health insurance premiums for 2026.
Medicare Part B premiums are jumping 12% in 2026. Learn about new costs, Advantage plan cuts, and the enrollment deadline ...
The monthly premium for Medicare Part B will rise significantly next year from $185 a month in 2025. Here's what it means for ...
Medicare alone can leave major gaps in coverage. Discover four costly expenses it doesn't cover and learn how you can prepare financially for them.
Smart Medigap Plans, a Texas-based Medicare Supplement Insurance Agency, has expanded its comprehensive Medicare insurance ...
Questions about the terminated Medicare Advantage plans and confusion from the federal government are driving a high number ...
Tribune Content Agency on MSN
Medicare to cover obesity drugs under Trump deal for as little as $50
The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results